glp-1 curb resM HUM Nutrition Flatter Me Fiber

The most common side effects are injection site inflammation or swelling

The LEADER trial showed that liraglutide reduced the risk of major cardiovascular events in people with type 2 diabetes.[4] Soon after, SUSTAIN-6 demonstrated similar benefits with semaglutide.[5] Then came REWIND, which suggested that cardiovascular protection could extend even to patients without established cardiovascular disease.[6] The SELECT trial made headlines because it showed cardiovascular benefits in people with overweight or obesity who did not have diabetes, a finding that challenged long-held assumptions about who might benefit from these medicines.[7] Most recently, an international trial called SOUL, which tested an oral form of semaglutide, included 788 Indian patients across 32 centres

If uncontrolled, it can cause pain and discomfort and lead to several pathological conditions

As we look ahead, here are a couple of key developments to watch for that will expand your future options: More Approved Oral Versions: Expect the FDA to approve new oral medications, including higher doses of existing drugs and entirely new compounds like Orforglipron